碳氧甲基基托和基托作为生物活性输送系统:一篇评论
Parinaz Sadat Alemi1, Marjan Mohamadali2, Samira Arabahmadi2
1Department of Biological Sciences, University of Texas at Dallas, Richardson, Texas, USA.
Biotechnology and applied biochemistry
|April 24, 2025
概括
碳氧甲基基托 (CMC) 对药物输送系统的基托 (CTS) 具有更好的性能. 这篇评论详细介绍了CMC的细节.
科学领域:
- 生物材料科学 生物材料科学
- 聚合物化学 聚合物化学
- 纳米技术 纳米技术
背景情况:
- 生物活性剂 (BA) 需要有效的传递系统来治疗疾病.
- 酸盐 (CTS) 是一个有前途的生物材料,但具有诸如溶解性差和快速释放等局限性.
- 碳氧甲基基托 (CMC) 是一种衍生物,旨在克服CTS的局限性.
研究的目的:
- 审查CTS和CMC的物理和化学特性.
- 讨论CMC作为各种生物活性剂的输送系统的生物医学应用.
- 探索CMC在药物,基因和蛋白质输送,微流体和癌症治疗方面的潜力.
主要方法:
- 关于奇托和碳甲基奇托的科学出版物的文献综述.
- 与CTS相比,分析CMC的化学变化和由此产生的特性.
- 检查使用CMC报告的生物医学应用和交付策略.
主要成果:
- 与CTS相比,CMC具有更好的溶解性,生物相容性和生物降解性.
- 在CTS中添加卡基和甲基,提高了其生物活性和适用于药物输送的适用性.
- 在提供药物,基因和蛋白质方面,CMC显示出潜力,在微流体和癌症治疗方面有应用.
结论:
- 在开发先进的生物医学输送系统方面,CMC是CTS的优质替代品.
- CMC的独特特性促进了生物活性剂的有针对性和受控的释放.
- 对基于CMC的系统的进一步研究对各种治疗应用具有重大前景.
相关概念视频
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
148
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
148
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
854
Indirect-acting cholinergic agonists, or anticholinesterases, enhance the body's cholinergic activity by inhibiting acetylcholine's breakdown. They are categorized as reversible or irreversible agents based on their mechanism of action. They are further classified into short-acting, intermediate-acting, and long-acting agents based on their duration of action.
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
854
Cholinergic Antagonists: Pharmacokinetics
373
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations, while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
373
Direct-Acting Cholinergic Agonists: Pharmacokinetics
976
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
976
Drug Delivery: Overview
248
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
248


